Shared decision-making is crucial, incorporating discussion of treatment goals, potential risks, expected benefits, cost considerations, and alternative options
When Early Dosing is Not Recommended While the 72-hour rule provides a safety window, there are specific situations where you should avoid taking your dose early
However, distinguishing between normal cold sensitivity and symptoms requiring clinical attention is important
These factors, combined with robust clinical evidence demonstrating efficacy in glycemic control and weight management, ensure North America retains the largest market share for GLP-1 receptor agonists globally
Does my insurance cover the recommended medication, and are there more affordable alternatives if coverage is an issue
Experts warn about possible risks, including a lack of effectiveness, unregulated compounded versions, contamination, overdose, and other safety concerns